Further investigation of the customer issue included a review of the complaint text, in-house testing, a search for similar complaints, and a review of labeling.Return material was not available from the customer.An accuracy testing protocol was executed; testing met the acceptance criteria and determined the reagent is performing acceptably.Tracking and trending did not identify an adverse trend for the lot in question.Labeling was reviewed and found to be adequate.Based on the available information no product deficiency and no malfunction of the architect cyclosporine reagent, list 01l75, lot 43438m500, was identified.
|